Adrián Posado Fernández

Ph.D. | CAPM-PMI | PM2

Santiago de Compostela, Galicia, Spain

About

Strategic project manager with 3+ years managing portfolios of national, European (MSCA, ERC, Health, DigitalEU) and privately funded initiatives across academic, clinical and industrial healthcare environments. Proven track record coordinating multidisciplinary teams, interacting with public authorities and private stakeholders, and delivering complex biotech and IVD (In Vitro Diagnostics) innovation projects. Deep understanding of healthcare administration, public procurement processes, and medical device development.

Experience

  • Independent Expert & Evaluator at European Commission
    Oct 2025 - Present · 10 mos

    MSCA-PF 2025 & 2026 Calls Independent Expert Evaluator ESR elaboration CR development

  • Project Manager at CiMUS (Center for Research in Molecular Medicine and Chronic Diseases)
    May 2023 - Present · 3 yrs 3 mos

    Project Manager at Gene Regulatory Control in Disease Group (CiMUS) Management of 10+ Research & Innovation projects funded by EU, AEI, GAIN and the AECC -> Coordination of MSCA-DN RBP-ReguNet Project (GA Nº101073094) -> Coordination of MSCA-DN DECODES Project (GA Nº101312753) -> Participation in the proposal development of the MSCA-COFUND TALENTGAL (GA Nº101261801) Communication, Dissemination, Monitoring, Reporting Training programmes Proposal writing Results exploitation and technology transfer Organization of events and international conferences

  • Project manager at Quibim
    Oct 2022 - Feb 2023 · 5 mos

  • Postdoctoral Researcher at Health Research Institute of Santiago de Compostela
    Feb 2019 - Feb 2022 · 3 yrs 1 mo

    Postdoctoral position at NEURAL Group. - Biochemical characterisation & preclinical therapeutic efficacy evaluation in animal models of novel tau-targeting monoclonal antibodies. - PoC of innovative immunoassays and neuroimaging (PET, MRI) diagnostic tools based in antibodies, aptamers, and nanostructures. - Clinical analysis and medical reporting of molecular biomarkers’ of neurology patients and maintenance of clinical samples biobank. - Data analysis and interpretation. Writing of scientific and technical evaluation reports. - Development of three products with potential IP/patent exploitation.

  • Marie Skłodowska-Curie ESR at STAB VIDA Lda.
    May 2014 - May 2017 · 3 yrs 1 mo

    EXTRABRAIN Early Stage Researcher (Marie-Skłodowska Curie Initial Training Network). Development, characterization and in vivo testing of several new anti-Amyloid Beta and anti-Tau monoclonal antibodies with theranostic purposes within Alzheimer´s Disease (AD).